Active ingredientCinepazide MaleateCat. No. P-C169-001CAS 26328-04-1Family · Pharmaceutical analytical standards
Cinepazide
A piperazine-based vasodilator that appears to work by enhancing A2 adenosine receptors, used for cardiovascular and cerebrovascular diseases. It was discovered in France in 1969 and launched as a tablet in 1976. This family brings together the active ingredient and other impurities.
Did you know?It came out of research on piperazines bearing cinnamoyl groups; many years later, in 2010, its injectable form, introduced in China in 2002, became the country's best-selling drug.
Go to the active ingredient →Active ingredientCinepazide MaleateCat. No. P-C169-001CAS 26328-04-1
ImpurityCinepazide Impurity ECat. No. P-C169-002CAS 39890-45-4
Impurity3',4',5'-Trimethoxycinnamoyl chlorideCat. No. P-C169-003CAS 10263-19-1
Impurity3,4,5-Trimethoxycinnamic acidCat. No. P-C169-004CAS 20329-98-0
ImpurityCinepazide Impurity 1Cat. No. P-C169-005CAS 88197-50-6
ImpurityCinepazide Impurity 2Cat. No. P-C169-006
ImpurityCinepazide Impurity 3Cat. No. P-C169-007CAS 701954-63-4
ImpurityCinepazide Impurity 4Cat. No. P-C169-008
ImpurityCinepazide N-OxideCat. No. P-C169-009CAS 1227926-25-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.